MBOT — Microbot Medical Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 883975 ·
Last close
$1.88
Market Cap
$126.27M
52W High
$2.77
52W Low
$1.66
ADV30
1,687,470
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 105,000 | 2,000 | -4,320,000 | -3,671,000 | 78,066,000 | 3,657,000 | 3,961,000 |
| Dec 2025 | 0 | — | -4,138,000 | -3,464,000 | 81,544,000 | 3,912,000 | 3,990,000 |
| Sep 2025 | 0 | — | -3,861,000 | -3,577,000 | 81,760,000 | 6,704,000 | 3,536,000 |
| Jun 2025 | 0 | — | -3,723,000 | -3,500,000 | 33,131,000 | 4,082,000 | 2,774,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,225,000
Investing CF
$-42,557,000
Financing CF
$58,434,000
CapEx
$-155,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.30
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-107,757,000
Inventory
$2,257,000
Receivables
$105,000
ST Investments
$68,843,000
EBIT TTM
$-16,042,000
Pretax Income TTM
$-14,212,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$105,000
EBITDA
$-15,998,000
Free Cash Flow
$-11,582,250
Enterprise Value
$50,637,936
Total Cash
$72,500,000
Total Debt
$898,000
Shares Out
67,164,801
Trailing EPS
$-0.26
Book Value
$1.10
ROE
-27.6%
ROA
-18.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -14,743,000 | -13,142,000 | 81,544,000 | 3,990,000 | — | -13,046,000 |
| Dec 2024 | 0 | -11,625,000 | -11,443,000 | 6,031,000 | 2,501,000 | — | -8,827,000 |
| Dec 2023 | 0 | -10,136,000 | -10,740,000 | 8,327,000 | 3,826,000 | — | -8,533,000 |
| Dec 2022 | 0 | -13,437,000 | -13,168,000 | 9,537,000 | 2,248,000 | — | -11,549,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.32
Max Pain — expiry 2028-01-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.00 · spot: $1.88 · call volume: 181 · put volume: 108
Expected Move to 2028-01-21:
±$2.30
(122.34%) —
implied range
$-0.42 –
$4.18
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CVRX | CVRx, Inc. | $128.17M | $4.83 | — |
| AVHHL | AVITA Medical, Inc. | $130.03M | $0.85 | — |
| RCEL | AVITA Medical, Inc. | $121.26M | $3.94 | — |
| NNOX | Nano-X Imaging Ltd. | $120.39M | $1.73 | — |
| GUTS | FRACTYL HEALTH, INC. | $134.85M | $0.85 | — |
News headlines (Yahoo Finance, 1h cache)
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
2026-06-16 12:30 · Yahoo
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
2026-06-09 12:30 · Yahoo
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
2026-06-02 12:30 · Yahoo
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
2026-05-26 12:30 · Yahoo
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
2026-05-19 13:35 · Yahoo
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans
2026-05-16 13:24 · Yahoo
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs
2026-05-15 13:56 · Yahoo
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
2026-05-14 12:30 · Yahoo
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
2026-05-13 22:40 · Yahoo
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
2026-05-05 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.